Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccine developments.

× No keyword cloud information.

15 in total

1. DNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc.

Authors: Lian-San Zhao; Shan Qin; Tao-You Zhou; Hong Tang; Li Liu; Bing-Jun Lei
Journal: World J Gastroenterol Date: 2000-04 Impact factor: 5.742

Review 2. Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".

Authors: Kimberly A Schoenly; David B Weiner
Journal: J Virol Date: 2007-11-07 Impact factor: 5.103

3. Novel antigen delivery technologies: a review.

Authors: Deepika Jain; Vikas Jain; Ranjit Singh
Journal: Drug Deliv Transl Res Date: 2011-04 Impact factor: 4.617

4. Adjuvant effects mediated by the carbohydrate recognition domain of Agrocybe aegerita lectin interacting with avian influenza H₉N₂ viral surface glycosylated proteins.

Authors: Li-Bao Ma; Bao-Yang Xu; Min Huang; Lv-Hui Sun; Qing Yang; Yi-Jie Chen; Ya-Lin Yin; Qi-Gai He; Hui Sun
Journal: J Zhejiang Univ Sci B Date: 2017 Aug. Impact factor: 3.066

5. The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors.

Authors: Joeli A Brinkman; Xuemei Xu; W Martin Kast
Journal: Vaccine Date: 2007-01-10 Impact factor: 3.641

Review 6. Technologies to improve immunisation safety.

Authors: C J Clements; M T Aguado; L Jódar
Journal: Drug Saf Date: 2001 Impact factor: 5.606

7. Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickens.

Authors: Deyuan Li; Maoyun Xue; Chen Wang; Junbao Wang; Puyan Chen
Journal: Clin Vaccine Immunol Date: 2011-07-27

Review 8. Old and new: recent innovations in vaccine biology and skin T cells.

Authors: Thomas S Kupper
Journal: J Invest Dermatol Date: 2012-01-12 Impact factor: 8.551

9. Vaccine strategies to prevent rheumatic fever.

Authors: E R Brandt; M F Good
Journal: Immunol Res Date: 1999 Impact factor: 2.829

10. Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors.

Authors: Sabine Schenck; Elke Kehm; Alberto L Epstein; Hanswalter Zentgraf; Martin Müller; Charles W Knopf
Journal: Virus Genes Date: 2008-06-12 Impact factor: 2.332